Ruiying Liu

National Key Laboratory Of Intelligent Tracking And Forecasting For Infectious Diseases
Changhongjie, China

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 20 publications

Engineering Escherichia coli to biosynthesize O-polysaccharide-derived recombinant glycoconjugate vaccines against pathogenic serotypes O8 and O9a.

Engineering Escherichia coli to biosynthesize O-polysaccharide-derived recombinant glycoconjugate vaccines against pathogenic serotypes O8 and O9a.

Journal: Carbohydrate polymers

Published: October 16, 2025

Fabrication of Single-Bacterium Microgel with Gas-Shearing Strategy for Precision Probiotic Delivery in IBD Therapy.

Fabrication of Single-Bacterium Microgel with Gas-Shearing Strategy for Precision Probiotic Delivery in IBD Therapy.

Journal: Research (Washington, D.C.)

Published: August 13, 2025

RstAB activates type 1 fimbriae to promote uropathogenic Escherichia coli bladder invasion.

RstAB activates type 1 fimbriae to promote uropathogenic Escherichia coli bladder invasion.

Journal: iScience

Published: July 19, 2025

The reactive oxygen species-induced small RNA CsrO promotes the survival of Cronobacter sakazakii in macrophages and systemic infection within the host.

The reactive oxygen species-induced small RNA CsrO promotes the survival of Cronobacter sakazakii in macrophages and systemic infection within the host.

Journal: Food research international (Ottawa, Ont.)

Published: July 11, 2025

Salmonella exploits host- and bacterial-derived β-alanine for replication inside host macrophages.

Salmonella exploits host- and bacterial-derived β-alanine for replication inside host macrophages.

Journal: eLife

Published: June 19, 2025

Engineered bacterial therapy suppresses Enterohemorrhagic Escherichia coli through metabolic competition and virulence silencing.

Engineered bacterial therapy suppresses Enterohemorrhagic Escherichia coli through metabolic competition and virulence silencing.

Journal: Nature communications

Published: June 08, 2025

Small molecule inhibitor targets OmpV to treat pandemic Vibrio cholerae infection.

Small molecule inhibitor targets OmpV to treat pandemic Vibrio cholerae infection.

Journal: Nature communications

Published: February 28, 2025

Development of a high-efficiency N-acetylneuraminic acid production platform through multi-pathway synergistic engineering.

Development of a high-efficiency N-acetylneuraminic acid production platform through multi-pathway synergistic engineering.

Journal: Trends in biotechnology

Published: December 21, 2024

Fishing out AIEC with FimH capturing microgels for inflammatory bowel disease treatment.

Fishing out AIEC with FimH capturing microgels for inflammatory bowel disease treatment.

Journal: Nature communications

Published: December 18, 2024

Targeting Brain Drug Delivery with Macromolecules Through Receptor-Mediated Transcytosis.

Targeting Brain Drug Delivery with Macromolecules Through Receptor-Mediated Transcytosis.

Journal: Pharmaceutics

Published: December 13, 2024

Low leucine levels in the blood enhance the pathogenicity of neonatal meningitis-causing Escherichia coli.

Low leucine levels in the blood enhance the pathogenicity of neonatal meningitis-causing Escherichia coli.

Journal: Nature communications

Published: September 30, 2024

Two-component system RstAB promotes the pathogenicity of adherent-invasive Escherichia coli in response to acidic conditions within macrophages.

Two-component system RstAB promotes the pathogenicity of adherent-invasive Escherichia coli in response to acidic conditions within macrophages.

Journal: Gut microbes

Published: May 21, 2024

Showing 1-12 of 20

Last Updated: 09/26/2026